Three seminars organized on September 20th, 21st and 22nd.
The seminars on September 21st and 22nd are for Italian speakers only.
Pharmacometrics – Practical approaches to dose optimization (CME)
Fragile patient (Italian Seminar, ECM)
The application of TDM protocols returns significant improvements in the management of pharmacological therapies. These lead to the exploitation of the therapeutic benefit of drugs while sparing patients from toxicities. The control of the disease and the reduction of its severity are important in fragile patients to achieve a well-being state. The diagnosis of a chronic complex disease that naturally tends to worsen, likely associated with comorbidities, frequently requiring the administration of combined pharmacological therapies is a critical factor that makes the patient vulnerable. In the last decades, the increasing life expectancy (for example, thanks to the successful progresses in medicine) have increased the number of fragile patients, while the complexity of their characteristics has become more multifaceted. For these reasons, TDM has gained a growing role in patients’ management, a central topic in the IATDM-CT Congresses. Therefore, the present symposium will present and debate the need for personalized medicine in fragile patients starting from the clinicians’ perspective in two precise settings: the aged people and those who received a transplanted organ. In this manner, physicians will discuss their expectations, while the representatives and members of the IATDM-CT will collect those needs, discuss possible strategies and elaborate appropriate TDM plans. The symposium will widen the audience and disseminate the activities of the IATDM-CT members across Italian scientific societies.
TMD of monoclonal antibodies in rheumatology and gastroenterology (Italian Seminar, ECM)
Biotechnologies have increased the therapeutic armamentarium for severe diseases both in children and in adult patients. Monoclonal antibodies (mABs) received much attention in some therapeutic areas. Indeed, the chronic use of chemical drugs in rheumatology and gastroenterology may be associated with severe toxic effects. With the progressive prescription and administration of mABs, the demand for personalized medicine has become evident to counteract the variable pharmacokinetics among patients, control the disease and reduce the risk of toxicities. These needs strongly support the adoption of TDM protocols. However, some issues of mABs TDM are not yet completely solved. Indeed, some factors are still debated and require a critical discussion: the proactive and the reactive approaches, patients’ characteristics, the severity of the disease and the coadministration of immunomodulatory drugs. In addition to these, the availability of appropriate instrumental platforms represents another area of intense research and development. The coordinated efforts of physicians, pharmacologists and biochemists may overcome these issues. Speakers of the present symposium will introduce and discuss the medical needs and TDM opportunities while using the mABs, thus sharing contributes from representatives of IATDM-CT and Italian scientific societies.
Il Seminario è accreditato ai fini ECM per le seguenti figure professionali:
- Biochimica di laboratorio
- Laboratorio di analisi chimico clinica
- Medici di laboratori
- Tecnici di laboratorio
|ITERSOCIETAL SEMINAR FEE / QUOTA SEMINARI INTERSOCETARI*
|ONE FEE / QUOTA SINGOLA
*The price displayed is intended for one intersocietal seminar and is VAT included.